EBOV-IN-9

EBOV-IN-9

• UNSPSC Description: EBOV-IN-9 (compound 2b) is Diphyllin derivative that blocks Ebola viral entry with an EC50 of 40 nM. EBOV-IN-9 against EBOV-infected monocyte-derived macrophages with an EC50 of 107 nM[1].
• Target Antigen: Filovirus
• Type: Reference compound
• Related Pathways: Anti-infection
• Applications: COVID-19-anti-virus
• Field of Research: Infection
• Assay Protocol: https://www.medchemexpress.com/ebov-in-9.html
• Smiles: O=C1OCC2=C(OC3COCC3)C4=CC(OC)=C(OC)C=C4C(C5=CC=C(OCO6)C6=C5)=C12
• Molecular Weight: 450.44
• References & Citations: [1]lLaura M. Sanford, et al. Evaluation of Potency and Metabolic Stability of Diphyllin-derived Vacuolar-ATPase Inhibitors. European Journal of Medicinal Chemistry. 28 May 2024, 116537.
• Shipping Conditions: Room temperature
• Clinical Information: No Development Reported